Letter to cancer center directors: Progress in quantitative imaging as a means to predict and/or measure tumor response in cancer therapy trials.

Mountz JM, Yankeelov TE, Rubin DL, Buatti JM, Erikson BJ, Fennessy FM, Gillies RJ, Huang W, Jacobs MA, Kinahan PE, Laymon CM, Linden HM, Mankoff DA, Schwartz LH, Shim H, Wahl RL
J Clin Oncol. 2014 32 (19): 2115-6

PMID: 24868025 · PMCID: PMC4861229 · DOI:10.1200/JCO.2014.55.8866

MeSH Terms (12)

Antineoplastic Agents Clinical Trials as Topic Diagnostic Imaging Disease Progression Humans Inflammation National Cancer Institute (U.S.) Neoplasms Predictive Value of Tests Research Support as Topic Treatment Outcome United States

Connections (1)

This publication is referenced by other Labnodes entities: